Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer

NCT00047255 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

263

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: trastuzumab
DRUG: carboplatin
DRUG: docetaxel
BIOLOGICAL: trastuxumab
DRUG: Docetaxel

Sponsor

Jonsson Comprehensive Cancer Center